Mammoet installs huge modules at GlaxoSmithKline plant

D.Ann Shiffler Editor in Chief, American Cranes & Transport

02 February 2022

Mammoet used a gantry to lift the modules in a very tight workspace.

A $400 million investment in GlaxoSmithKline’s Upper Merion biopharmaceutical manufacturing plant in Pennsylvania involved the installation of several modules under tight restrictions, incluidng time, space, climate and ground forces. Mammoet executed the movement of the components to their final location and provided specialized millwrighting expertise to precicely place, align, and…

Log in to continue reading

Log in for free access to this article and more, including:

  • Industry news and expert insight
  • Digital magazines and reports
  • Newsletters covering the topics that matter to you

If you haven’t completed your free registration yet, we’ll ask you for a few details before returning you to the article.

Login
CONNECT WITH THE TEAM
D.Ann Shiffler Editor, American Cranes & Transport Tel: +1 512 869 8838 E-mail: [email protected]
Alex Dahm Editorial Manager Tel: +44 (0) 1892 786206 E-mail: [email protected]
Mitchell Keller Managing Editor Tel: +1 (262) 483-3726 E-mail: [email protected]
Simon Battersby Sales Manager Tel: +44 (0) 1892 786223 E-mail: [email protected]
CONNECT WITH SOCIAL MEDIA